Bigelow Lab

University of California, San Francisco

OTOLARYNGOLOGY

San Francisco · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

The role of hearing loss in cognitive impairment and Alzheimer’s disease pathology

PROJECT SUMMARY Alzheimer’s disease (AD) is a large and growing worldwide public health epidemic. Because there is no cure for AD, much clinical effort is focused on interventions targeting potentially modifiable risk factors. Recent epidemiological studies have identified hearing loss (HL) as a major modifiable risk factor for AD. These findings have prompted debate over whether HL specifically accelerates AD pathology, or if the link instead reflects shared risk factors such as age, genetics, or metabolic conditions. Because human studies are necessarily correlational, an animal model is necessary to determine whether HL specifically influences AD pathology. We address this question in…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at University of California, San Francisco